Skip to content
Vaskapu u. 10-14. B.ép. III/10. | 1097 Budapest (HUNGARY)
+36 (30) 977 6092
info@laboratorystandards.eu
Home
Product categories
Documents
Research Chemicals for Life Science and Drug Discovery
Catalogue
Pipettes
Liquid handling
PURA Water Baths
Laboratory Supplies
Karl Fischer Reagents and Standards
Phospholipids & Fatty Acids
Stable Isotope Labeled Compounds, NMR Tubes
Contact
Privacy Policy
Menu
Home
Product categories
Documents
Research Chemicals for Life Science and Drug Discovery
Catalogue
Pipettes
Liquid handling
PURA Water Baths
Laboratory Supplies
Karl Fischer Reagents and Standards
Phospholipids & Fatty Acids
Stable Isotope Labeled Compounds, NMR Tubes
Contact
Privacy Policy
Search
Code
Description
Unit
1448672
Moxifloxacin Related Compound G (15 mg) (1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid, monohydrochloride)
15 mg
1448901
Mupirocin (50 mg)
50 mg
1448912
Mupirocin Calcium (200 mg)
200 mg
1448923
Mupirocin Lithium (100 mg)
100 mg
1448956
Mycophenolate Mofetil (200 mg)
200 mg
1448967
Mycophenolate Mofetil Related Compound A (15 mg) (2-morpholinoethyl-(E)-6-(1,3-dihydro-4,6-dihydroxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate)
15 mg
1448559
Moxidectin (200 mg)
200 mg
1448560
Moxidectin System Suitability Mixture (50 mg)
50 mg
1448606
Moxifloxacin Hydrochloride (200 mg)
200 mg
1448617
Moxifloxacin Related Compound A (25 mg) (1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid)
25 mg